Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New 7T MRI could spot hidden brain tumors before they grow

NCT ID NCT07175077

First seen Nov 01, 2025 · Last updated Jun 23, 2026 · Updated 34 times

Summary

This study is testing whether a powerful 7T MRI scan can detect tiny brain metastases earlier than standard 1.5T/3T scans in people with small-cell lung cancer who choose not to have preventive brain radiation. Twenty participants will get a 7T brain scan followed by up to a year of standard scans. The goal is to see if the 7T scan spots tumors sooner, which could lead to earlier treatment decisions.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SMALL-CELL LUNG CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University of Missouri

    RECRUITING

    Columbia, Missouri, 65212, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

7T MRI scan

What this could lead to

If successful, this could show that 7T MRI finds brain metastases much earlier than standard scans, helping doctors monitor high-risk patients more closely.

What could go wrong

This is a very small early study (20 people) and only tests detection, not treatment. The 7T MRI may not prove better in practice or may find false positives.

Conditions

The condition(s) this trial relates to.

brain cancer small cell lung carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.